National Comprehensive Cancer Network

Educational Events & Programs

NCCN Clinical Practice Guidelines in Oncology Symposium™
Breast Cancer
and 2007 San Antonio Breast Cancer Symposium Review

Friday, January 18, 2008 (Chicago, Illinois)

Register now to secure a seat at this symposium.

Program Overview:
The NCCN Clinical Practice Guidelines in Oncology™ consist of a comprehensive set of guidelines detailing the sequential management decisions and interventions for the malignancies that affect 97% of all patients with cancer. Developed by faculty at NCCN Member Institutions using a consensus-based process with explicit review of pertinent data, the guidelines panels develop over 100 separate pathways. The NCCN Breast Cancer Guidelines Panel has developed and continually updates algorithms for management of non-invasive and invasive breast cancer. This symposium is an in-depth analysis of the evidence and clinical decision-making that led to the development of these guidelines. Topics include diagnosis, staging work-ups with discussion of prognostic markers, local therapy, sentinel lymph node biopsy, and the use of hormonal, cytotoxic and biologic therapies in the adjuvant, neoadjuvant, and metastatic settings. The format includes presentation of case reports and audience feedback to highlight application of the guidelines in clinical practice. Participants will have the opportunity to discuss the guidelines with their developers and provide input for consideration in future updates. In addition, a there will be a special presentation on oncofertility and a review of important studies and updates from the 2007 San Antonio Breast Cancer Symposium.

Educational Objectives:
Following this program, participants should be able to:

• Identify the principles of guideline development and methods of guideline implementation
• Discuss how guideline implementation can be applied to assessment of quality care in oncology
• Explain clinical algorithms for the treatment of breast cancer
• Describe the diagnostic and staging work-up for each stage of breast cancer
• Identify the role of prognostic markers in breast cancer
• State the role of sentinel lymph node biopsy and axillary dissection
• Describe the precepts of surgery and radiation in the management of Stage 0, I, II, and III breast cancer
• Outline the current recommendations for hormonal and cytotoxic agents as adjuvant therapy for Stage I and II breast cancer
• Recognize the role of neoadjuvant chemotherapy in Stage II and III breast cancer
• Differentiate agents available for the treatment of advanced or recurrent breast cancer including chemotherapy, biologic therapy, and hormonal therapy
• Recognize the impact of chemotherapy and radiation therapy on follicle development and oocyte quality
• State new advances in biomaterials and their role in the in vitro growth of immature ovarian follicles resulting in live animal births
• Describe the potential of in vitro oocyte maturation as a method to preserve future fertility in young women and girls and the rationale for banking human ovarian tissue at this time
• Interpret the results of recently reported clinical trials for the treatment of breast cancer in the adjuvant and metastatic settings
• Compare data from clinical trials of novel chemotherapy agents and combinations

Intended Audience:
This educational activity is designed to meet the needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.

Tentative Agenda:

Accreditation:
Physicians
The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

NCCN designates this educational activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses
This activity is approved for 5.8 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Pharmacists
The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program is acceptable for 5.75 hours (.575 CEUs) of continuing education credit in states that recognize ACPE-accredited providers.

(ACPE ID #781-999-08-003-L01-P)

In order to receive a statement of credit, conference participants will need to attend the conference, participate in learner assessment activities, and complete the activity evaluation form. Partial credit will be awarded. Statements of credit will be mailed within 6 to 8 weeks of the meeting. Pharmacists should note that they must attend a minimum of one hour to be eligible for credit. Please see the registration page for fees.

Faculty Disclosure
All faculty participating in NCCN continuing education activities are expected to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME’s and ANCC’s Standards for Commercial Support. Full disclosure of faculty relationships will be made prior to the activity.

Program Location:
Prentice Women’s Hospital
3rd Floor Conference Room L
250 E. Superior
Chicago, Illinois
(Directions)

Hosted By:
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Contributors:
Supported by educational grants from Abraxis BioScience, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Novartis Oncology, and Roche.

Registration Information:

If cancellation is necessary, please notify NCCN. A substitute attendee may be sent in your place. Registration fees are non-refundable.

Register now to secure a seat at this symposium.